← SynDRA
TROFINETIDE
SynDRA canonical compound SYN0005933 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATF3 | IFNG | IL6 | TNF |
|---|
| Mechanism of action | anti-inflammatory agent | cytokine production inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- anti-inflammatory agent
- cytokine production inhibitor
Drug classes
- Cytochrome P450 3A4 Inhibitors
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 1B3 Inhibitors
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- daybue
- ACP-2566
- NNZ-2566
- Trofinetida
- Daybue
- Glypromate analogs (oral, neuroprotection), Neuren
- NNZ-2566 (oral, neurodegeneration/injury)
- NNZ-2566 (oral, neurodegeneration/injury), Neuren
- Z2ME8F52QL
- NNZ 2566
- L-Glutamic acid, glycyl-2-methyl-L-prolyl-
- Glycyl-2-methyl-L-prolyl-L-glutamic acid
- DAYBUE
- trofinetida
- trofinetidum
- RefChem:59119
- DTXCID701766129
- Trofinetide [INN]
- Trofinetide [USAN]
- Trofinetide(NNZ2566)
- glycyl-L-2-methylprolyl-L-glutamic acid
- Trofinetide (>90%)
- UNII-Z2ME8F52QL
- Daybue (TN)
- DAYBUE STIX
- Trofinetide (USAN/INN)
- Trofinetide [USAN:INN]
- TROFINETIDE [WHO-DD]
- orb1307647
- SCHEMBL1170014
- GTPL12482
- NNZ2566
- CHEBI:229599
- GLXC-15737
- DJB40076
- EX-A7815
- MFCD28502204
- WHO 10076
Look up TROFINETIDE in the interactive SynDRA portal →